Trials (Turku University Hospital Cancer Centre) - Revision history

Francine at 14:22, 14 December 2025

2025-12-14T14:22:51Z

← Older revision		Revision as of 14:22, 14 December 2025
Line 4:		Line 4:
	<span style="display:none">finlandcountry</span>		<span style="display:none">finlandcountry</span>
	Go back to [[Turku University Hospital Cancer Centre]] page		Go back to [[Turku University Hospital Cancer Centre]] page

			=== Trials: How to participate ===
			'''Contact information:''' [https://www.tyks.fi/en/about-tyks/tyks-organization/result-groups/result-group-gynaecology-and-paediatrics/pediatric-clinical-trials-unit-pedctu-turku Click here to access].


	'''NCTID''': NCT03486873		'''NCTID''': NCT03486873
Line 510:		Line 514:
	<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>		<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
	<span style="display:none">hasCancerType::unknown</span>		<span style="display:none">hasCancerType::unknown</span>
			<span style="display:none">isTrial</span>

Lucas: Update categories.

2025-12-06T12:42:30Z

Update categories.

← Older revision		Revision as of 12:42, 6 December 2025
Line 489:		Line 489:
	<span style="display:none">hasTrialTitle::Platine, Avastin and OLAparib in 1st Line</span>		<span style="display:none">hasTrialTitle::Platine, Avastin and OLAparib in 1st Line</span>
	<span style="display:none">hasTrialTitle::A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia</span>		<span style="display:none">hasTrialTitle::A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia</span>
			<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
			<span style="display:none">hasCancerType::C00-C97: All cancer types</span>
			<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
			<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
			<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
			<span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
			<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
			<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
			<span style="display:none">hasCancerType::C50: Breast cancer</span>
			<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
			<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
			<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
			<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
			<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
			<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
			<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
			<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
			<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
			<span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
			<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
			<span style="display:none">hasCancerType::unknown</span>

Francine at 20:27, 2 December 2025

2025-12-02T20:27:48Z

← Older revision		Revision as of 20:27, 2 December 2025
Line 2:		Line 2:
	<span style="display:none">forproviders</span>		<span style="display:none">forproviders</span>
	<span style="display:none">forresearchers</span>		<span style="display:none">forresearchers</span>
	<span style="display:none">~~finland~~</span>		<span style="display:none">finlandcountry</span>
	Go back to [[Turku University Hospital Cancer Centre]] page		Go back to [[Turku University Hospital Cancer Centre]] page

Lucas: Update categories.

2025-12-02T14:01:04Z

Update categories.

@@ Line 1: / Line 1: @@
-{{forpatients}}
+<span style="display:none">forpatients</span>
-{{forproviders}}
+<span style="display:none">forproviders</span>
-{{forresearchers}}
+<span style="display:none">forresearchers</span>
-{{finland}}
+<span style="display:none">finland</span>
 Go back to [[Turku University Hospital Cancer Centre]] page
@@ Line 445: / Line 445: @@
   '''Recruitment Status''': RECRUITING
   '''Condition''': Leukemia, Acute Lymphoblastic

Victor at 23:54, 5 November 2024

2024-11-05T23:54:34Z

← Older revision		Revision as of 23:54, 5 November 2024
Line 2:		Line 2:
	{{forproviders}}		{{forproviders}}
	{{forresearchers}}		{{forresearchers}}
			{{finland}}
	Go back to [[Turku University Hospital Cancer Centre]] page		Go back to [[Turku University Hospital Cancer Centre]] page

Francine at 15:21, 4 January 2024

2024-01-04T15:21:47Z

Show changes

Francine: Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Turku University Hospital Cancer Centre page '''NCTID''': NCT03486873 '''Title''': Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) '''Study Summary''': The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in part..."

2023-12-01T21:11:48Z

Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Turku University Hospital Cancer Centre page '''NCTID''': NCT03486873 '''Title''': Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) '''Study Summary''': The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in part..."

Show changes